based on the inclusion criteria. To maintain a 2:1 ratio between the sizes
of the control group/experimental groups, data from 449 randomly
selected patients in the control groups were excluded; this resulted in
obstetric-outcome data being included from 51 patients in the fibroid
group and 102 patients in the control group (Fig. 1). Data from 11–14-
week, 22–24-week, and 28–32-week ultrasonography fibroid examinations
were available for 31 patients (Fig. 2).